专利检索 ap:("Targacept Inc." OR "Toler, Steve" OR "Lippiello, Patrick M." OR "Cullison, Scott N." OR "Bencherif, Merouane") AND inv:"CULLISON, Scott, N." 第 1 页

1.

发明公开
METHODS FOR PREVENTING THE DEVELOPMENT OF RETINOPATHY BY THE ORAL ADMINISTRATION OF NNR LIGANDS 审中-公开
标题翻译：程序，以防止视网膜病变的发展BY NNR配体的口服给药

公开(公告)号：EP2296640A1

公开(公告)日：2011-03-23

申请号：EP09747285.6

申请日：2009-05-11

申请人： Targacept Inc. , Toler, Steve , Lippiello, Patrick M. , Cullison, Scott N. , Bencherif, Merouane

发明人： TOLER, Steven M. , LIPPIELLO, Patrick, M. , CULLISON, Scott, N. , BENCHERIF, Merouane

IPC分类号： A61K31/13 , A61K31/4545 , A61K31/439 , A61K31/506 , A61K45/06 , A61P27/02

CPC分类号： A61K31/13 , A61K31/439 , A61K31/4545 , A61K31/506

摘要： Method and compositions for delaying the onset or progression of retinopathy, including administering at least one neuronal nicotinic ligand are disclosed.